0001567619-21-001335.txt : 20210121 0001567619-21-001335.hdr.sgml : 20210121 20210121162202 ACCESSION NUMBER: 0001567619-21-001335 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210119 FILED AS OF DATE: 20210121 DATE AS OF CHANGE: 20210121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anicetti Vincent R CENTRAL INDEX KEY: 0001733375 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 21542251 MAIL ADDRESS: STREET 1: COHERUS BIOSCIENCES, INC. STREET 2: 333 TWIN DOLPHIN DRIVE, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 4 1 doc1.xml FORM 4 X0306 4 2021-01-19 0 0001512762 Coherus BioSciences, Inc. CHRS 0001733375 Anicetti Vincent R COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 0 1 0 0 Chief Operating Officer Common Stock 2021-01-19 4 M 0 2500 2.5005 A 62239 D Common Stock 2021-01-19 4 S 0 2500 17.9408 D 59739 D Stock Option (Right to Buy) 2.5005 2021-01-19 4 M 0 2500 0.00 D 2024-06-30 Common Stock 2500 2488 D Includes 52,083 restricted stock units. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person. The transaction was executed in multiple trades in prices ranging from $17.76 to $18.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. All of the shares underlying this option are vested and exercisable as of the date hereof. /s/ Jean-Frederic Viret, as Attorney-in-Fact for Vincent R. Anicetti 2021-01-21